Number of shares outstanding for ACADIA Pharmaceuticals (ACAD)

Number of shares outstanding as of December 2024 : 165,974,000

According to ACADIA Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 165,974,000. At the end of 2024 the company had 165,974,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for ACADIA Pharmaceuticals from 2003 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.16 B	0.71%
2023	0.16 B	1.74%
2022	0.16 B	0.7%
2021	0.16 B	1.01%
2020	0.15 B	3.09%
2019	0.15 B	17.37%
2018	0.13 B	6.05%
2017	0.12 B	2.41%
2016	0.12 B	19.76%
2015	0.10 B	1.36%
2014	99.85 M	11.56%
2013	89.5 M	47.65%
2012	60.61 M	14.81%
2011	52.8 M	37.56%
2010	38.38 M	2.68%
2009	37.38 M	0.66%
2008	37.13 M	0.52%
2007	36.94 M	24.26%
2006	29.73 M	27.37%
2005	23.34 M	40.38%
2004	16.62 M	46.32%
2003	11.36 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Vanda Pharmaceuticals VNDA	58,261,961	-64.90%	🇺🇸 USA
Pfizer PFE	5,667,000,000	3,314.39%	🇺🇸 USA
Eli Lilly LLY	901,000,000	442.86%	🇺🇸 USA
Johnson & Johnson JNJ	2,407,298,000	1,350.41%	🇺🇸 USA
Bristol-Myers Squibb BMY	2,028,000,000	1,121.88%	🇺🇸 USA
Adamas Pharmaceuticals ADMS	28,158,200	-83.03%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions